Your browser doesn't support javascript.
loading
Functional analysis of a de novo variant in the neurodevelopment and generalized epilepsy disease gene NBEA.
Boulin, Thomas; Itani, Omar; El Mouridi, Sonia; Leclercq-Blondel, Alice; Gendrel, Marie; Macnamara, Ellen; Soldatos, Ariane; Murphy, Jennifer L; Gorman, Mark P; Lindsey, Anika; Shimada, Shino; Turner, Darian; Silverman, Gary A; Baldridge, Dustin; Malicdan, May C; Schedl, Tim; Pak, Stephen C.
Afiliación
  • Boulin T; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon 69008, France.
  • Itani O; C. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
  • El Mouridi S; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon 69008, France.
  • Leclercq-Blondel A; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon 69008, France.
  • Gendrel M; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon 69008, France; Institut de Biologie de l'Ecole Normale Supérieure (IBENS), Ecole Normale Supérieure, CNRS, INSERM, Université Paris Sciences et Lettres Research University, Paris 75005, France.
  • Macnamara E; Undiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
  • Soldatos A; Undiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
  • Murphy JL; Undiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
  • Gorman MP; Department of Neurology, Neuroimmunology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Lindsey A; C. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
  • Shimada S; Undiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
  • Turner D; C. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
  • Silverman GA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
  • Baldridge D; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
  • Malicdan MC; Undiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
  • Schedl T; C. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Genetics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
  • Pak SC; C. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA. Electronic address: stephen.pak@wustl.edu.
Mol Genet Metab ; 134(1-2): 195-202, 2021.
Article en En | MEDLINE | ID: mdl-34412939
ABSTRACT
Neurobeachin (NBEA) was initially identified as a candidate gene for autism. Recently, variants in NBEA have been associated with neurodevelopmental delay and childhood epilepsy. Here, we report on a novel NBEA missense variant (c.5899G > A, p.Gly1967Arg) in the Domain of Unknown Function 1088 (DUF1088) identified in a child enrolled in the Undiagnosed Diseases Network (UDN), who presented with neurodevelopmental delay and seizures. Modeling of this variant in the Caenorhabditis elegans NBEA ortholog, sel-2, indicated that the variant was damaging to in vivo function as evidenced by altered cell fate determination and trafficking of potassium channels in neurons. The variant effect was indistinguishable from that of the reference null mutation suggesting that the variant is a strong hypomorph or a complete loss-of-function. Our experimental data provide strong support for the molecular diagnosis and pathogenicity of the NBEA p.Gly1967Arg variant and the importance of the DUF1088 for NBEA function.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Proteínas Portadoras / Epilepsia / Trastornos del Neurodesarrollo / Proteínas del Tejido Nervioso Tipo de estudio: Diagnostic_studies Límite: Animals / Child / Female / Humans Idioma: En Revista: Mol Genet Metab Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Proteínas Portadoras / Epilepsia / Trastornos del Neurodesarrollo / Proteínas del Tejido Nervioso Tipo de estudio: Diagnostic_studies Límite: Animals / Child / Female / Humans Idioma: En Revista: Mol Genet Metab Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Francia